Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 3:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Not Applicable
1 (33.3%)Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis
Phase 3
Suspended
- Conditions
- Age-Related Maculopathy
- First Posted Date
- 2007-04-17
- Last Posted Date
- 2007-11-07
- Lead Sponsor
- OccuLogix
- Target Recruit Count
- 325
- Registration Number
- NCT00460967
- Locations
- 🇺🇸
Retinal Consultants of Arizona, Phoenix, Arizona, United States
🇺🇸Associated Retina Consultants, LTD., Phoenix, Arizona, United States
🇺🇸Mayo Clinic Hospital, Phoenix, Arizona, United States
Long-Term Efficacy in AMD of Rheopheresis in North America
Not Applicable
- Conditions
- Macular Degeneration
- First Posted Date
- 2006-09-25
- Last Posted Date
- 2006-09-25
- Lead Sponsor
- OccuLogix
- Target Recruit Count
- 120
- Registration Number
- NCT00380172
- Locations
- 🇺🇸
Retina Vitreous Associates, Beverly Hills, California, United States
🇺🇸Aran Eye Associates, Coral Gables, Florida, United States
🇺🇸Retina Health Care, Ft. Myers, Florida, United States
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
Phase 3
- Conditions
- Macular Degeneration
- First Posted Date
- 2004-03-01
- Last Posted Date
- 2008-05-09
- Lead Sponsor
- OccuLogix
- Target Recruit Count
- 180
- Registration Number
- NCT00078221
- Locations
- 🇺🇸
Retina Vitreous Associates, Beverly Hills, California, United States
🇺🇸Aran Eye Associates, Coral Gables, Florida, United States
🇺🇸Retina Health Care, Ft. Myers, Florida, United States
News
No news found